Psoriasis
News
Briakinumab Boosts Quality of Life for Psoriasis Patients
Major Finding: Scores on the Dermatology Life Quality Index declined by a mean of 10.3points with briakinumab, 8.1 points with etanercept, and 3.0...
News
Canakinumab Proves Safe, Effective for Long-Term CAPS Treatment
Major Finding: Of 38 canakinumab-naive patients, 68% achieved a complete response based on physician global assessment of disease activity and...
News
Juvenile Localized Scleroderma: Fewer Flares With Methotrexate
Major Finding: At the end of the 12-month study, 17 of 24 patients randomized to receive placebo and prednisone experienced a relapse, compared...
News
Coal Tar Making a Psoriasis Comeback
News
Smoking Cessation Enhances Antimalarial Response in Cutaneous Lupus
News
Get an Early Start on Biologics to Treat IBD
News
FDA Searches for Clinical Trial Middle Ground at Biosimilar Hearing
News
Favorable 3-Year Safety Update for Ustekinumab in Psoriasis
Major Finding: Rates of malignancies, serious infections, and cardiovascular events in ustekinumab patients remained stable over time without any...
News
NIH at Forefront of New Clinical Trials Push, Director Says
News
Azathioprine Beats Mycophenolate Mofetil in Vasculitis Relapse Prevention
Major Finding: Patients taking mycophenolate mofetil had a 1.80 adjusted hazard ratio for relapse of ANCA-associated vasculitis, compared with...